These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10080352)

  • 21. Virulence studies on chromosomal alpha-toxin and theta-toxin mutants constructed by allelic exchange provide genetic evidence for the essential role of alpha-toxin in Clostridium perfringens-mediated gas gangrene.
    Awad MM; Bryant AE; Stevens DL; Rood JI
    Mol Microbiol; 1995 Jan; 15(2):191-202. PubMed ID: 7746141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic effects of alpha-toxin and perfringolysin O in Clostridium perfringens-mediated gas gangrene.
    Awad MM; Ellemor DM; Boyd RL; Emmins JJ; Rood JI
    Infect Immun; 2001 Dec; 69(12):7904-10. PubMed ID: 11705975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and evaluation of indirect enzyme-linked immunosorbent assays for the determination of immune response to multiple clostridial antigens in vaccinated captive bred southern white rhinoceros (Ceratotherium simum simum).
    Buys A; Crafford J; van Heerden H
    Acta Vet Scand; 2020 Oct; 62(1):57. PubMed ID: 33028379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enzyme-linked immunosorbent assay for rapid detection of toxins from Clostridium perfringens.
    Nagahama M; Kobayashi K; Ochi S; Sakurai J
    FEMS Microbiol Lett; 1991 Nov; 68(1):41-4. PubMed ID: 1769554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clostridium perfringens toxin types from wild-caught Atlantic cod (Gadus morhua L.), determined by PCR and ELISA.
    Aschfalk A; Müller W
    Can J Microbiol; 2002 Apr; 48(4):365-8. PubMed ID: 12030710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production and purification of Clostridium perfringens alpha-toxin using a protein-hyperproducing strain, Bacillus brevis 47.
    Nagahama M; Michiue K; Sakurai J
    FEMS Microbiol Lett; 1996 Dec; 145(2):239-43. PubMed ID: 8961562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toxin-neutralizing antibodies protect against Clostridium perfringens-induced necrosis in an intestinal loop model for bovine necrohemorrhagic enteritis.
    Goossens E; Verherstraeten S; Valgaeren BR; Pardon B; Timbermont L; Schauvliege S; Rodrigo-Mocholí D; Haesebrouck F; Ducatelle R; Deprez PR; Van Immerseel F
    BMC Vet Res; 2016 Jun; 12(1):101. PubMed ID: 27297520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A cellular deficiency of gangliosides causes hypersensitivity to Clostridium perfringens phospholipase C.
    Flores-Díaz M; Alape-Girón A; Clark G; Catimel B; Hirabayashi Y; Nice E; Gutiérrez JM; Titball R; Thelestam M
    J Biol Chem; 2005 Jul; 280(29):26680-9. PubMed ID: 15919667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In silico, in vitro and in vivo analysis of binding affinity between N and C-domains of Clostridium perfringens alpha toxin.
    Uppalapati SR; Kingston JJ; Qureshi IA; Murali HS; Batra HV
    PLoS One; 2013; 8(12):e82024. PubMed ID: 24349173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dissecting the contributions of Clostridium perfringens type C toxins to lethality in the mouse intravenous injection model.
    Fisher DJ; Fernandez-Miyakawa ME; Sayeed S; Poon R; Adams V; Rood JI; Uzal FA; McClane BA
    Infect Immun; 2006 Sep; 74(9):5200-10. PubMed ID: 16926413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential protective immunogenicity of recombinant Clostridium perfringens α-β2-β1 fusion toxin in mice, sows and cows.
    Zeng J; Deng G; Wang J; Zhou J; Liu X; Xie Q; Wang Y
    Vaccine; 2011 Jul; 29(33):5459-66. PubMed ID: 21641956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in the carboxy-terminal (Putative phospholipid binding) domains of Clostridium perfringens and Clostridium bifermentans phospholipases C influence the hemolytic and lethal properties of these enzymes.
    Jepson M; Howells A; Bullifent HL; Bolgiano B; Crane D; Miller J; Holley J; Jayasekera P; Titball RW
    Infect Immun; 1999 Jul; 67(7):3297-301. PubMed ID: 10377104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic characteristics of toxigenic Clostridia and toxin gene evolution.
    Popoff MR; Bouvet P
    Toxicon; 2013 Dec; 75():63-89. PubMed ID: 23707611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The first strain of Clostridium perfringens isolated from an avian source has an alpha-toxin with divergent structural and kinetic properties.
    Justin N; Walker N; Bullifent HL; Songer G; Bueschel DM; Jost H; Naylor C; Miller J; Moss DS; Titball RW; Basak AK
    Biochemistry; 2002 May; 41(20):6253-62. PubMed ID: 12009886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel toxin homologous to large clostridial cytotoxins found in culture supernatant of Clostridium perfringens type C.
    Amimoto K; Noro T; Oishi E; Shimizu M
    Microbiology (Reading); 2007 Apr; 153(Pt 4):1198-1206. PubMed ID: 17379729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Naturally occurring Clostridium perfringens nontoxic alpha-toxin variant as a potential vaccine candidate against alpha-toxin-associated diseases.
    Schoepe H; Pache C; Neubauer A; Potschka H; Schlapp T; Wieler LH; Baljer G
    Infect Immun; 2001 Nov; 69(11):7194-6. PubMed ID: 11598102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality assurance of C. perfringens epsilon toxoid vaccines--ELISA versus mouse neutralisation test.
    Rosskopf-Streicher U; Volkers P; Noeske K; Werner E
    ALTEX; 2004; 21 Suppl 3():65-9. PubMed ID: 15057410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The C-terminal domain of Clostridium perfringens alpha toxin as a vaccine candidate against bovine necrohemorrhagic enteritis.
    Goossens E; Verherstraeten S; Valgaeren BR; Pardon B; Timbermont L; Schauvliege S; Rodrigo-Mocholí D; Haesebrouck F; Ducatelle R; Deprez PR; Van Immerseel F
    Vet Res; 2016 Apr; 47(1):52. PubMed ID: 27121298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clostridium perfringens α-Toxin Impairs Innate Immunity via Inhibition of Neutrophil Differentiation.
    Takehara M; Takagishi T; Seike S; Ohtani K; Kobayashi K; Miyamoto K; Shimizu T; Nagahama M
    Sci Rep; 2016 Jun; 6():28192. PubMed ID: 27306065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The luxS gene is involved in cell-cell signalling for toxin production in Clostridium perfringens.
    Ohtani K; Hayashi H; Shimizu T
    Mol Microbiol; 2002 Apr; 44(1):171-9. PubMed ID: 11967077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.